UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - TANDEM DIABETES CARE INC ownership

TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 271 filers reported holding TANDEM DIABETES CARE INC in Q4 2023. The put-call ratio across all filers is 1.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of TANDEM DIABETES CARE INC
ValueSharesWeighting
Q2 2024$6,170,494
+67.9%
153,152
+47.6%
0.00%
+100.0%
Q1 2024$3,674,813
+34.3%
103,779
+12.2%
0.00%0.0%
Q4 2023$2,735,262
+38.4%
92,470
-2.8%
0.00%0.0%
Q3 2023$1,976,203
-47.1%
95,147
+3.5%
0.00%
-50.0%
Q2 2023$3,734,2110.0%91,9530.0%0.00%0.0%
Q1 2023$3,734,211
-6.0%
91,953
+4.1%
0.00%0.0%
Q4 2022$3,972,142
-99.9%
88,368
+7.2%
0.00%0.0%
Q3 2022$3,945,615,000
-29.2%
82,458
-12.4%
0.00%
-33.3%
Q2 2022$5,571,732,000
-50.3%
94,133
-2.3%
0.00%
-40.0%
Q1 2022$11,200,587,000
-17.2%
96,316
+7.1%
0.01%0.0%
Q4 2021$13,531,447,000
+19.6%
89,898
-5.2%
0.01%0.0%
Q3 2021$11,315,673,000
+24.7%
94,787
+1.7%
0.01%
+25.0%
Q2 2021$9,076,901,000
+20.0%
93,192
+8.8%
0.00%
+33.3%
Q1 2021$7,561,437,000
-62.2%
85,682
-59.0%
0.00%
-66.7%
Q4 2020$19,990,136,000
-13.3%
208,927
+2.8%
0.01%
-25.0%
Q3 2020$23,065,812,000
+16.5%
203,223
+1.6%
0.01%0.0%
Q2 2020$19,793,002,000
+65.5%
200,091
+7.6%
0.01%
+33.3%
Q1 2020$11,962,344,000
-13.1%
185,895
-19.5%
0.01%
+12.5%
Q4 2019$13,768,361,000
+319.9%
230,974
+315.5%
0.01%
+300.0%
Q3 2019$3,278,934,000
+8.3%
55,594
+18.5%
0.00%0.0%
Q2 2019$3,027,794,000
+15.8%
46,928
+14.0%
0.00%0.0%
Q1 2019$2,613,660,000
+81.0%
41,160
+8.3%
0.00%
+100.0%
Q4 2018$1,443,733,00038,0230.00%
Other shareholders
TANDEM DIABETES CARE INC shareholders Q4 2023
NameSharesValueWeighting ↓
Consonance Capital Management LP 1,022,257$60,293,0005.97%
APIS CAPITAL ADVISORS, LLC 50,000$2,949,0004.62%
SECTORAL ASSET MANAGEMENT INC 432,815$25,527,0004.40%
CROWN ADVISORS MANAGEMENT, INC. 75,000$4,424,0002.96%
OBERWEIS ASSET MANAGEMENT INC/ 199,410$11,761,0002.66%
Asymmetry Capital Management, L.P. 18,995$1,120,0002.40%
Redmile Group, LLC 1,160,401$68,440,0002.29%
FRIESS ASSOCIATES LLC 501,985$29,607,0002.29%
Atika Capital Management LLC 142,000$8,375,0001.76%
Chicago Capital, LLC 433,083$25,543,0001.71%
View complete list of TANDEM DIABETES CARE INC shareholders